Review Article
PET/fMRI for precise localization of abnormal brain activity: a mini review
Yufeng Zang, Feng Feng, Li Huo, Biao Li, Xiaoli Lan, Jie Lu, Jiahe Tian, Zhoushe Zhao, Yiyun Huang
Published 2017-12-25
Cite as Chin J Nucl Med Mol Imaging, 2017, 37(12): 802-808. DOI: 10.3760/cma.j.issn.2095-2848.2017.12.014
Abstract
Many brain disorders do not show visible lesions and most likely are resulted from abnormalities in regional brain activity or connectivity. Conventional diagnostic neuroimaging techniques are not capable of precisely localizing the abnormal brain activity, but the recently developed integrated PET/MR technology may have the potential to bridge this gap. Integrated PET/MR has been used in clinical practice. However, its primary application is still a combination of functional PET imaging and structural MRI. Simultaneous PET/fMRI, a " functional+ functional" imaging technique, holds the advantages of high spatial and temporal resolution, high sensitivity and specificity, and non-invasiveness. Globally, simultaneous PET/fMRI research is still in its beginning stage, and a few initial PET/fMRI studies have shown that voxel-wise correlation between PET and fMRI metrics was not very high, indicating that they may reflect very different aspects of brain activity. To date more than 5 integrated PET/MR scanners have been set up in mainland China. China has the largest patient population, rapidly developing PET imaging techniques, and well-established capabilities in fMRI neuroimaging analytics. PET/fMRI studies require multi-disciplinary collaborations in nuclear medicine, radiology, chemistry, medical physics, computation science, and cognitive neuroscience. At the moment, the research management system in Chinese hospitals is not conducive to such collaborations and further improvement is needed to encourage multi-disciplinary research such as PET/fMRI. Given the known advantages in patient population and other resources, multi-center and multi-disciplinary studies hold the potential to put China at the leading edge of PET/fMRI research and produce high value results that will advance both neuroimaging sciences and future patient care in brain disorders.
Key words:
Brain disease; Diagnosis; Positron-emission tomography; Magnetic resonance imaging; Trends
Contributor Information
Yufeng Zang
Center for Cognition and Brain Disorders, Institutes of Psychological Sciences, Hangzhou Normal University, Zhejiang Key Laboratory for Research in Assessment of Cognitive Impairments, Hangzhou 311121, China
Feng Feng
Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
Li Huo
Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
Biao Li
Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Xiaoli Lan
Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Jie Lu
Department of Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
Jiahe Tian
Department of Nuclear Medicine, General Hospital of PLA, Beijing 100853, China
Zhoushe Zhao
MR Modality, GE Healthcare China, Beijing 100176, China
Yiyun Huang
PET Center, Yale University